Skip to content

Clinical trials

Observational Liver Cirrhosis trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Observational Status: Unknown status Clear all

140 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20072
20082
20092
20105
20114
20124
20134
20143
20154
20167
201715
20189
20197
202013
202116
202219
202319
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status140

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University11
Beijing Friendship Hospital5
Fifth Affiliated Hospital, Sun Yat-Sen University4
Institute of Liver and Biliary Sciences, India4
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran4
Medical University of Vienna3
Post Graduate Institute of Medical Education and Research, Chandigarh3
Seoul National University Hospital3
Third Affiliated Hospital, Sun Yat-Sen University3
West China Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis140
Non-alcoholic Fatty Liver Disease17
Hypertension, Portal16
Fibrosis11
Fatty Liver10
Carcinoma, Hepatocellular9
Hepatitis B7
Liver Diseases7
Acute-On-Chronic Liver Failure6
Esophageal and Gastric Varices5

Trials

Showing 1 to 25 of 140. Each trial links to its page on Pharma Observatory.

40 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.